By Siddhi Mahatole and Puyaan Singh (Reuters) -INmune Bio said on Monday its experimental Alzheimer's drug failed to improve ...

(Reuters) -INmune Bio said on Monday its experimental Alzheimer's drug failed to improve cognitive functions in patients with ...

There are currently no approved treatments in Canada that can slow the progression of Alzheimer's, only drugs to quiet ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

A once-a-day pill called blarcamesine may slow memory loss and preserve independence—without the scary side effects or ...

Scientists have identified specific brain cells which respond most to exercise, an advance that could lead to a pill to boost ...

For years, researchers have seen a connection between exercise and the progression of cognitive disorders such as Alzheimer's ...

A once-a-day pill that could completely revolutionise the treatment of Alzheimer’s disease has reached a significant ...

In the case of the amyloid drugs, Eisai Biogen's Leqembi (lecanemab) and Eli Lilly's Kisunla (donanemab) – there are also ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...

Kevin Smith, a resident of Clifton Park, is experiencing the benefits of a recently approved Alzheimer's drug, Leqembi, as he ...

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...